Leprosy is one of the world’s oldest infectious diseases – yet there are still around 200,000 cases every year¹. As the only supplier of multidrug therapy, in January 2026 Novartis renewed its partnership to provide the medicine via the WHO, protecting vital access to treatment.

Novartis-Harvard team identifies a new type of cell that is key to the disease.

In Wendi Yajnik’s quest to find new technologies that could transform medicine, relationships are priority No. 1.

Novartis is strongly committed in helping and supporting employees impacted by cancer through the program Ensemble – Caring for Colleagues (Ensemble).

Neurological diseases develop out of sight. Novartis neuroscientists are bringing them into the light, using human brain cells grown in the lab.

Dr. Botond Roska says we should keep our eyes on gene therapy.

The best treatment for multifaceted diseases like NASH may be combinations of drugs.

Caring for someone with heart failure can be both demanding and rewarding. Learn about the impact of being a carer and the support that carers need.

Novartis researchers are collaborating with tech startup PathAI to search for hidden information in pathology slides.